RxDoctor Payments Data

Justin Haydel, MD

Neurological Surgery · Metairie, LANPI 1851568174

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 121 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Medtronic accounts for 62.1% of it on its own, with 10 other manufacturers making up the rest. That places this record below the midpoint for neurological surgery clinicians in LA, where the typical reported total is $5,328.

$5,328in general payments, 2019–2025

Across 121 payments — averaging $44.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$3K
  • Johnson & Johnson$588
  • Boston Scientific$530
  • Globus Medical$231
  • Innovasis Inc$172
  • Stryker$139
  • plus $360 from 5 others

What the payments were for

  • Food & beverage$5,328100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,328 in reported general payments places this provider in the 50th percentile of 116 neurological surgery providers in Louisiana.

See all neurological surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$62,502
Medicare patients
87
Services billed
243

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin25$257
Pregabalin14$243
Tramadol Hcl32$226
Methocarbamol32$204
Tizanidine Hcl22$194
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen13$132
Cyclobenzaprine Hcl15$114

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Metairie

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →